Pfizer and BioNTechâs COMIRNATYÂź Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
NEW YORK and MAINZ, GERMANY, AUGUST 27, 2025 â Pfizer Inc. (NYSE: PFE, âPfizerâ) and BioNTech SE (Nasdaq: BNTX, âBioNTechâ) today announced the U.S. Food and Drug Administration (FDA) has approved ...